Clinical trial
A Randomized, Double-blind, Controlled, 6-week Trial to Assess the Impact of Novel Digital Interventions Designed to Improve Cognitive Dysfunction as Adjunct Therapy to Antidepressant Medication in Adults With Major Depressive Disorder
NCT03310281 is registered in ClinicalTrials.gov with Akili Interactive Labs, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Controlled, 6-week Trial to Assess the Impact of Novel Digital Interventions Designed to Improve Cognitive Dysfunction as Adjunct Therapy to Antidepressant Medication in Adults With Major Depressive Disorder
- Lead sponsor
- Akili Interactive Labs, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 4, 2017
- Completion date
- November 14, 2018
- Enrollment
- 84 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.